Autotelic
City Of Industry · Founded 2013
About Autotelic
Autotelic uses therapeutic drug monitoring to enhance the development of therapeutics. It is designed to Increase patent life, expand the therapeutic window, and shorten the clinical development path. Autotelic starts companies or invest in existing companies combining our TDM device with the licensed therapeutics to become a winning drug-device combination. It brings on experts and the experience needed for a successful biotechnology/pharma company. They take company through its logical exit points either M&A or to access the public markets so that sufficient funding is in place to fully develop the drug-device combination.
Company Facts
- Founded: 2013
- Legal name: Autotelic Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Last round: Debt Financing (Dec 2014)
- Website: autotelicinc.com
- Phone: (626) 964-5788
Canonical: https://fsome.com/organization/autotelic-8410824 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.